Parmax Pharma reports Rs 6 crore fire damage, claim unrecognised
Key highlights
- Parmax disclosed management-estimated fire damage of Rs 6 crore from 28 September 2026.
- Parmax notified its insurer of Rs 4.75 crore, with no insurance receivable recognised at 30 September 2026.
- Parmax reported half-year profit after tax of Rs 2.372453 crore before fire accounting.
- Cash and cash equivalents rose to Rs 7.085679 crore at 30 September 2026.
powered by IRIS

Parmax Pharma Limited disclosed that a 28 September 2026 fire at its Hadamtala factory in Rajkot caused management-estimated damage of Rs 6 crore, while no financial effect and no Rs 4.75 crore insurance claim receivable were recognised in the half-year accounts pending loss assessment, survey completion and insurer acceptance.
Know Parmax Pharma inside out
Results, valuation, peers and who's buying, in one view.
What happened at Parmax’s Rajkot factory?
A fire occurred at Parmax’s manufacturing facility at Hadamtala, District Rajkot, on 28 September 2026, damaging plant and machinery, finished material and semi-finished material. The auditor’s review report describes the affected categories as property, plant and equipment and inventories, and records management’s estimate of the damage at Rs 6 crore.
Parmax said it was still ascertaining the loss when it issued unaudited results for the quarter and half year ended 30 September 2026 on 16 November 2026. The filing does not allocate the Rs 6 crore estimate among machinery, plant, finished goods and semi-finished material, nor does it quantify any production interruption or inventory destruction.
The fire took place two days before the 30 September 2026 reporting date, and Parmax stated that no effect had been given in the quarter and half-year financial statements. This means the reported balances at 30 September 2026, including property, plant and equipment of Rs 10.906852 crore and inventories of Rs 4.812159 crore, do not identify the assets affected by the incident.
Why did Parmax not recognise the fire loss and insurance claim?
Parmax did not reflect the fire loss in its results because management was still determining the amount of loss from the 28 September 2026 incident. Separately, the auditor said no insurance claim receivable was recognised because the loss survey had not been completed and the insurer had not accepted the claim.
The amount intimated to the insurance company was Rs 4.75 crore, compared with the management-estimated Rs 6 crore damage. The Rs 1.25 crore difference is a comparison of the two disclosed amounts, not a stated uninsured loss, because neither Parmax nor its auditor provided an allocation or explanation for the difference.
The auditor cited Indian Accounting Standard 37, known as Ind AS 37, in explaining why the insurance receivable was unrecognised. It included the issue in an emphasis-of-matter paragraph but said its limited-review conclusion was not modified in respect of the fire, the pending survey or the pending insurer acceptance.
How did Parmax’s half-year results compare before fire accounting?
Parmax reported total income of Rs 24.252391 crore for the half year ended 30 September 2026, up from Rs 4.486883 crore in the corresponding half year ended 30 September 2025. Revenue from operations increased to Rs 19.925205 crore from Rs 4.473181 crore, while other income rose to Rs 4.327186 crore from Rs 0.013701 crore.
The company reported profit after tax of Rs 2.372453 crore for the 2026 half year, against a loss of Rs 2.842863 crore a year earlier. That move from loss to profit was reported before any accounting for the Rs 6 crore estimated fire damage or recognition of the Rs 4.75 crore notified insurance amount.
Other income included a creditor debt write-back that Parmax put at Rs 2.32 crore. The auditor’s emphasis-of-matter note described long-outstanding related-party balance write-backs aggregating Rs 2.24 crore, including amounts payable for capital goods, a loan from Malwin Pharma Pvt. Ltd. and an unsecured loan from managing director Umang A. Gosalia.
Got a follow-up? Ask IRIS
What do Parmax’s balance sheet and cash flows show?
Parmax reported cash and cash equivalents of Rs 7.085679 crore at 30 September 2026, compared with Rs 0.649684 crore at 31 March 2026. Total assets increased to Rs 38.053397 crore from Rs 28.053281 crore over the same six-month period, while trade receivables rose to Rs 11.507312 crore from Rs 3.162759 crore.
Net cash used in operating activities was Rs 4.648183 crore for the half year ended 30 September 2026, compared with Rs 3.335117 crore used in the prior-year period. Investing activities used Rs 3.941360 crore, while financing activities generated Rs 15.025538 crore, resulting in a net increase in cash and cash equivalents of Rs 6.435995 crore.
Property, plant and equipment stood at Rs 10.906852 crore at 30 September 2026, up from Rs 7.859858 crore at 31 March 2026. Parmax also said it did not charge depreciation on its clean-room plant and effluent treatment plant for the half year, while the auditor highlighted non-provision of depreciation on the effluent treatment plant in the September quarter due to non-usage and management’s assessment of useful life, residual value and recoverability.
What capital actions and segment disclosures did Parmax report?
Parmax’s board approved the allotment of 31,37,586 equity shares of face value Rs 10 each at Rs 36.50 per share on 29 August 2026. It also allotted 21,45,145 convertible warrants at Rs 36.50 each, with Rs 9.125 paid up per warrant, according to the financial-results notes.
Equity share capital in the balance sheet was Rs 8.125022 crore at 30 September 2026, compared with Rs 4.451150 crore at 31 March 2026. Total equity was Rs 9.367645 crore at the September date, compared with negative Rs 6.147752 crore at the March date, while the cash-flow statement records Rs 3.673872 crore from equity share capital and Rs 11.841525 crore from other equity.
Parmax operates in one pharmaceutical segment, so it provided no segment-level split for the 28 September fire or the half-year revenue of Rs 19.925205 crore. Its filing identifies its manufacturing activities as bulk drugs, drug intermediates and speciality chemicals, but does not disclose which products or operations were affected by the Hadamtala incident.
Conclusion
Parmax’s reported half-year profit of Rs 2.372453 crore and cash balance of Rs 7.085679 crore must be viewed alongside a fire estimate that remains outside the 30 September 2026 accounts. The company has disclosed Rs 6 crore of management-estimated damage, while the auditor says the Rs 4.75 crore insurance amount has not yet met the conditions for recognition as a receivable.
The next disclosed steps are completion of the insurance loss survey and the insurer’s acceptance or otherwise of the claim. Parmax has also not finalised the fire loss amount, so subsequent results may clarify the accounting effect on damaged property, plant, equipment and inventories, as well as any recovery recognised from insurance.


